疑似或已知铁过载患者的MRI R2*定量成像
这项回顾性横断面研究对81例已知或疑似铁过载成人行1.5 T屏气多回波梯度回波MRI,测量肝、脾、骨髓、胰腺、肾皮质、肾髓质及心肌R2*,分析器官间相关性及不同病因、治疗下的R2*差异,发现R2*可反映铁过载的程度、分布及病因与治疗差异。
要点
- 肝R2*与脾、骨髓、胰腺、心脏R2*的相关系数分别为0.49、0.33、0.27、0.34。
- 原发与继发性铁过载在肝、脾、骨髓、肾皮质、肾髓质的R2*差异有统计学意义(p<0.01)。
- 地中海贫血的肝、脾、骨髓R2*高于遗传性血色病(均p<0.01)。
核心结论
- R2*弛豫测量可显示不同器官间铁过载程度或分布的差异,并与基础病因及治疗相关。
研究设计与样本
- 回顾性横断面研究,经机构审查委员会批准,纳入81例已知或疑似铁过载的成人患者。
- 采用1.5 T屏气多回波梯度回波成像,分割肝、脾、骨髓、胰腺、肾皮质、肾髓质和心肌并测量R2*。
- 记录放血、输血和螯合治疗,分析采用相关性检验、Kruskal-Wallis检验及事后Dunn检验,p<0.01为显著。
诊断标准与关键数值
- 肝R2*与脾、骨髓、胰腺、心脏R2*的相关系数分别为0.49、0.33、0.27、0.34。
- 原发与继发性铁过载在肝(p<0.001)、脾(p<0.001)、骨髓(p<0.01)、肾皮质(p<0.001)、肾髓质(p<0.001)的R2*差异有统计学意义。
- 地中海贫血的肝、脾、骨髓R2*高于遗传性血色病(均p<0.01)。
- 镰状细胞病的肾皮质R2*高于遗传性血色病(p<0.001)和地中海贫血(p<0.001)。
- 总体上,分配至放血治疗的患者肝R2*有降低趋势,分配至输血和螯合治疗的患者肝R2*有升高趋势。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: R2* relaxometry is a quantitative method for assessment of iron overload. The purpose is to analyze the cross-sectional relationships between R2* in organs across patients with primary and secondary iron overload. Secondary analyses were conducted to analyze R2* according to treatment regimen.
METHODS: This is a retrospective, cross-sectional, institutional review board-approved study of eighty-one adult patients with known or suspected iron overload. R2* was measured by segmenting the liver, spleen, bone marrow, pancreas, renal cortex, renal medulla, and myocardium using breath-hold multi-echo gradient-recalled echo imaging at 1.5 T. Phlebotomy, transfusion, and chelation therapy were documented. Analyses included correlation, Kruskal-Wallis, and post hoc Dunn tests. p < 0.01 was considered significant.
RESULTS: Correlations between liver R2* and that of the spleen, bone marrow, pancreas, and heart were respectively 0.49, 0.33, 0.27, and 0.34. R2* differed between patients with primary and secondary overload in the liver (p < 0.001), spleen (p < 0.001), bone marrow (p < 0.01), renal cortex (p < 0.001), and renal medulla (p < 0.001). Liver, spleen, and bone marrow R2* were higher in thalassemia than in hereditary hemochromatosis (all p < 0.01). Renal cortex R2* was higher in sickle cell disease than in hereditary hemochromatosis (p < 0.001) and in thalassemia (p < 0.001). Overall, there was a trend toward lower liver R2* in patients assigned to phlebotomy and higher liver R2* in patients assigned to transfusion and chelation therapy.
CONCLUSION: R2* relaxometry revealed differences in degree or distribution of iron overload between organs, underlying etiologies, and treatment.
引用
- Aslan E, Luo JW, Lesage A, et al. MRI-based R2* mapping in patients with suspected or known iron overload. Abdom Radiol (NY). 2021. PMID: 33388804. doi:10.1007/s00261-020-02912-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。